SCL Science Inc. (KOSDAQ:246960)
2,175.00
-25.00 (-1.14%)
At close: Apr 2, 2026
SCL Science Market Cap
SCL Science has a market cap or net worth of 77.22 billion as of April 2, 2026. Its market cap has increased by 25.47% in one year.
Market Cap
77.22B
Enterprise Value
102.40B
Revenue
22.01B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,175.00
Market Cap Chart
Since February 1, 2019, SCL Science's market cap has decreased from 96.15B to 77.22B, a decrease of -19.69%. That is a compound annual growth rate of -3.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 73.99B | -5.31% |
| Dec 30, 2025 | 78.14B | 30.19% |
| Dec 30, 2024 | 60.02B | -6.50% |
| Dec 28, 2023 | 64.19B | 33.91% |
| Dec 29, 2022 | 47.93B | -21.46% |
| Dec 30, 2021 | 61.03B | -26.89% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 1, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DuChemBIO | 253.12B |
| CG MedTech | 220.97B |
| OSTEONIC | 131.80B |
| Sewoon Medical | 117.10B |
| JW Shinyak | 104.43B |
| KM Corporation | 47.16B |
| Wonbiogen | 46.96B |
| MEDYSSEY Co.,Ltd | 41.74B |